Help us reach $1,000,000! Match My Donation

Press Releases

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
March 06, 2012

Cancer Research Institute and Stand Up To Cancer Announce $6 Million Dream Team Grant

The Cancer Research Institute and Stand Up To Cancer, in partnership with the American Association for Cancer Research, have issued a call for letters of intent from scientists and clinical investigators interested in forming the SU2C-CRI Cancer Immunology Translational Research Dream Team.

February 12, 2012

Antibodies to Intracellular Cancer Antigens Combined with Chemotherapy Enhance Anti-cancer Immunity

Pre-clinical study by scientists funded by Cancer Research Institute and Ludwig Institute for Cancer Research confirmed that combining chemotherapy and immunotherapy in cancer treatment enhances the immune system's ability to find and eliminate cancer cells.

November 27, 2011

Lloyd J. Old, M.D., Father of Modern Tumor Immunology, Dies at 78 of Prostate Cancer

CRI announced today its founding scientific and medical director Lloyd J. Old, M.D., regarded as the “Father of Modern Tumor Immunology,” died early this morning at his home in New York City from prostate cancer. He was 78 years old.

November 08, 2011

Critical Value Demonstrated for Immune Assay Harmonization

The Association for Cancer Immunotherapy Immunoguiding Program and the Cancer Immunotherapy Consortium of CRI published a joint paper discussing recent results of independent international, cross-laboratory immune assay harmonization studies.

November 07, 2011

Cancer Immunotherapy Consortium Appoints New Leadership

Drs. James P. Allison, chair of the immunology program at Memorial Sloan-Kettering Cancer Center, and Axel Hoos, medical lead in immunology/oncology at Bristol-Myers Squibb, have been named directors of the CRI Cancer Immunotherapy Consortium (CIC), the premier academic-industry association dedicated to accelerating development of safe and effective cancer immunotherapies to patients.

*Immunotherapy results may vary from patient to patient.